CastleArk Management »

Intra Cellular Therapies shares owned by CastleArk Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by CastleArk Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.2M 50k 83.52
2024-09-30 $3.8M 52k 73.17
2024-03-31 $3.8M 54k 69.20
2023-12-31 $5.3M 74k 71.62
2023-09-30 $3.8M 74k 52.09
2023-06-30 $4.9M 77k 63.32
2023-03-31 $1.3M 24k 54.15
2022-12-31 $3.2M 61k 52.92
2022-09-30 $4.1M 88k 46.53
2022-06-30 $5.1M 90k 57.07
2022-03-31 $2.5M 40k 61.19

More positions owned by CastleArk Management

Advisors Inner Circle Fd Ii Castleark Large (CARK)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Spdr Series Trust Portfolio Intrmd (SPIB)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Us Treas Bd Etf (GOVT)
Broadcom (AVGO)
Lam Research Corp Com New (LRCX)
Netflix (NFLX)
Arista Networks Com Shs (ANET)
Charles Schwab Corporation (SCHW)

View all positions for CastleArk Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies